|
|
Volumn 306, Issue 5700, 2004, Pages 1277-
|
|
Estrogen's ties to COX-2 may explain heart disease gender gap
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELECOXIB;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
ESTROGEN;
FREE RADICAL;
NONSTEROID ANTIINFLAMMATORY AGENT;
PLACEBO;
PROSTACYCLIN;
PROSTACYCLIN RECEPTOR;
ROFECOXIB;
VALDECOXIB;
ISOENZYME;
MEMBRANE PROTEIN;
PROSTAGLANDIN SYNTHASE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PTGS2 PROTEIN, HUMAN;
ATHEROSCLEROSIS;
ATHEROSCLEROTIC PLAQUE;
CARDIOVASCULAR RISK;
DRUG EFFECT;
ENZYME SYNTHESIS;
ESTROGEN ACTIVITY;
ESTROGEN SYNTHESIS;
ESTROGEN THERAPY;
EXPERIMENTAL MODEL;
HEART DISEASE;
HEART PROTECTION;
HIGH RISK POPULATION;
MOUSE STRAIN;
NONHUMAN;
NOTE;
OUTCOMES RESEARCH;
OXIDATIVE STRESS;
PREMENOPAUSE;
PRIORITY JOURNAL;
PROSTAGLANDIN SYNTHESIS;
SEX DIFFERENCE;
ANIMAL;
ARTERIOSCLEROSIS;
ARTICLE;
BIOSYNTHESIS;
DISEASE PREDISPOSITION;
FEMALE;
GENETICS;
HUMAN;
MALE;
METABOLISM;
MOUSE;
PHYSIOLOGY;
SEXUAL DEVELOPMENT;
ANIMALS;
ARTERIOSCLEROSIS;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
DISEASE SUSCEPTIBILITY;
EPOPROSTENOL;
ESTROGENS;
FEMALE;
HUMANS;
ISOENZYMES;
MALE;
MEMBRANE PROTEINS;
MICE;
OXIDATIVE STRESS;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
RECEPTORS, EPOPROSTENOL;
SEX CHARACTERISTICS;
|
|
EID: 19744382551
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.306.5700.1277 Document Type: Note |
|
Times cited : (9)
|
|
References (0)
|